Vemurafenib-induced hyperkeratosis of the areola treated with topical adapelene.
Clin Exp Dermatol
; 41(2): 148-51, 2016 Mar.
Article
em En
| MEDLINE
| ID: mdl-25703642
ABSTRACT
We present a rare condition, hyperkeratosis of the areola, induced by vemurafenib. Only a few papers have described an association of BRAF inhibitors with hyperkeratosis of the areola and/or nipple. Vemurafenib is a selective BRAF inhibitor used in patients with unresectable or metastatic melanoma who are positive for the V600 mutation. This drug has been associated with numerous cutaneous side effects, both benign and malignant. We report a male patient with vemurafenib-induced hyperkeratosis of the areola managed successfully with a topical retinoid, and describe for the first time a treatment for this side effect.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Sulfonamidas
/
Anti-Inflamatórios não Esteroides
/
Fármacos Dermatológicos
/
Adapaleno
/
Indóis
/
Ceratose
/
Antineoplásicos
/
Mamilos
Limite:
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Clin Exp Dermatol
Ano de publicação:
2016
Tipo de documento:
Article
País de afiliação:
Reino Unido